Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shamez Ladhani and Gayatri Amirthalingam.
Shamez Ladhani
Connection Strength
2.523
Gayatri Amirthalingam
  1. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England. J Infect. 2021 11; 83(5):573-580.
    View in: PubMed
    Score: 0.240
  2. Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England. Euro Surveill. 2021 07; 26(28).
    View in: PubMed
    Score: 0.238
  3. Secondary Attack Rate and Family Clustering of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children of Healthcare Workers With Confirmed Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 07 01; 73(1):e260-e263.
    View in: PubMed
    Score: 0.238
  4. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020. EClinicalMedicine. 2021 Jul; 37:100948.
    View in: PubMed
    Score: 0.237
  5. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England. J Infect. 2021 07; 83(1):104-111.
    View in: PubMed
    Score: 0.236
  6. Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers. J Infect. 2021 05; 82(5):162-169.
    View in: PubMed
    Score: 0.234
  7. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health. 2021 06; 5(6):417-427.
    View in: PubMed
    Score: 0.234
  8. Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021. Euro Surveill. 2021 03; 26(12).
    View in: PubMed
    Score: 0.233
  9. Prioritising paediatric surveillance during the COVID-19 pandemic. Arch Dis Child. 2020 07; 105(7):613-615.
    View in: PubMed
    Score: 0.220
  10. Maternal vaccination against pertussis: a systematic review of the recent literature. Arch Dis Child Fetal Neonatal Ed. 2017 Sep; 102(5):F456-F463.
    View in: PubMed
    Score: 0.179
  11. Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 Jul; 22(7):928.
    View in: PubMed
    Score: 0.060
  12. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 05; 22(5):620-626.
    View in: PubMed
    Score: 0.058
  13. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021 02; 26(5).
    View in: PubMed
    Score: 0.058
  14. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study. Arch Dis Child. 2021 07; 106(7):680-686.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.